0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
The following section summarizes insights on GSK plc's EBITDA Margin:
We've identified the following companies as similar to GSK plc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EBITDA Margin in the efficiency category include:
Earnings before interest, taxes, depreciation and amortization (EBITDA) expressed as a percent of revenue.
The ebitda margin measures a company’s ebitda as a percentage of the revenue. The formula to calculate ebitda margin and an example calculation for GSK’s trailing twelve months is outlined below:
EBITDA Margin = EBITDA / Total Revenue
26.5% = 10.046 B / 37.919 B
The tables below summarizes GSK’s performance over the last five years:
| Fiscal Year | EBITDA | Revenue | Margin |
|---|---|---|---|
| 2020-12-31 | 9.068 B | 27.263 B | 33.3% |
| 2021-12-31 | 9.215 B | 29.343 B | 31.4% |
| 2022-12-31 | 10.491 B | 33.106 B | 31.7% |
| 2023-12-31 | 11.898 B | 35.02 B | 34.0% |
| 2024-12-31 | 10.046 B | 37.919 B | 26.5% |
The tables below summarizes GSK’s performance over the last four quarters:
| Quarter Ending | EBITDA | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | 3.27 B | 8.61 B | 38.0% |
| 2024-06-30 | 3.368 B | 9.303 B | 36.2% |
| 2024-09-30 | 1.943 B | 9.62 B | 20.2% |
| 2024-12-31 | 1.848 B | 9.81 B | 18.8% |
You can read more about EBITDA here.
The chart above depicts the distribution of ebitda margin for companies operating in the Healthcare sector in the Developed economic region. Over 1,910 companies were considered in this analysis, and 1,840 had meaningful values. The average ebitda margin of companies in the sector is -1,055.0% with a standard deviation of 4,219.4%.
GSK plc's EBITDA Margin of 26.5% ranks in the 91.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,916 |
| Included Constituents | 1,840 |
| Min | -46,520.8% |
| Max | 58.4% |
| Median | -9.4% |
| Mean | -1,055.0% |
| Standard Deviation | 4,219.4% |
You can find companies with similar ebitda margin using this stock screener.